Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease

2009 ◽  
Vol 33 (2) ◽  
pp. 349-352 ◽  
Author(s):  
Katsuyoshi Mizukami ◽  
Kimitaka Hatanaka ◽  
Yoshiro Tanaka ◽  
Shinji Sato ◽  
Takashi Asada
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Depressive Symptoms ◽  
Reuptake Inhibitor ◽  
Selective Serotonin ◽  
Therapeutic Effects ◽  
Noradrenaline Reuptake ◽  
Noradrenaline Reuptake Inhibitor

Application of PLGA nanoparticles to enhance the action of Duloxetine on microglia in neuropathic pain

2021 ◽  
Author(s):  
Song I Kim ◽  
Juhee Shin ◽  
Quangdon Tran ◽  
Hyewon Park ◽  
Hyeok Hee Kwon ◽  
...  
Keyword(s):  
Neuropathic Pain ◽  
Side Effects ◽  
Reuptake Inhibitor ◽  
Plga Nanoparticles ◽  
Selective Serotonin ◽  
Noradrenaline Reuptake ◽  
Noradrenaline Reuptake Inhibitor

Duloxetine (DLX) is a selective serotonin and noradrenaline reuptake inhibitor (SNRI) used for treatment of pain, but it has been reported to show side effects in 10–20% of patients. Its...

Depressive Symptoms and APOE ε2 Broad the Natural History in Presenilin-1 E280A Familial Early-Onset Alzheimer's Disease

2018 ◽  
Author(s):  
Natalia Acosta-Baena ◽  
Carlos Mario Lopera-Gómez ◽  
Mario César Jaramillo-Elorza ◽  
Margarita Giraldo-Chica ◽  
Mauricio Arcos-Burgos ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Depressive Symptoms ◽  
Natural History ◽  
Early Onset ◽  
Presenilin 1 ◽  
Early Onset Alzheimer’S Disease
Sign in / Sign up

Export Citation Format

Share Document